Novo Nordisk is embedding Anthropic's Claude models across its drug discovery operations as it races to keep pace with Eli Lilly in the obesity-drug market. The deal is part of a broader 2026 wave of pharma-AI tie-ups, though skeptics note none has yet produced an approved drug credited to the technology.
Qualified Health raised a $125 million Series B on March 26, 2026 led by New Enterprise Associates to expand its enterprise AI governance platform, which the company says now supports 400,000 users across health systems representing about 5% of U.S. hospital revenue.
Hamamatsu Photonics won FDA 510(k) clearance on September 2, 2026 for two NanoZoomer whole-slide imaging scanners for primary diagnostic use, breaking Leica Biosystems' near-lock on cleared digital pathology scanning hardware that AI diagnostic tools depend on.
AbbVie and Iambic Therapeutics announced a multi-year AI drug discovery collaboration on September 21, 2026 targeting small-molecule therapies in immunology, neuroscience and oncology, part of a wider wave of pharma-AI deals that also saw Novo Nordisk partner with Anthropic the same week.
Insilico Medicine published LongevityBench in Cell on September 17, 2026, a 17-task benchmark showing that 18 frontier AI systems from major developers all struggled with predicting biological age from molecular data, while the company's own compact Longevity-LLMs matched or beat much larger models.
Pearl became the first dental AI company cleared by the FDA for both 2D and 3D imaging as of December 2025, with the company citing clinical data showing diagnostic accuracy rising from 82% to 98% when dentists use its Second Opinion software.
Ergomotion launched its free AI-powered Sleep Assist app on August 1, 2026, turning its RIO Eco smart adjustable beds into contactless sleep monitors with an AI assistant that answers plain-language questions about a user's own nightly sleep data.
A NEJM AI study of 174,648 emergency department visits across three hospital sites found that an AI-informed triage tool cut median time to initial care by 33% and raised correct high-acuity identification from 78.8% to 83.1%.
Washington state authorized statewide Medicaid reimbursement for Intuition Robotics' ElliQ companion device on March 18, 2026, the first time any U.S. state has fully covered a social AI robot as a 'Smart Care Device' for home-based long-term care recipients.
UMass Memorial Health expanded Mednition's KATE AI triage tool to seven emergency departments systemwide, reporting a 44% drop in annual safety reports and a 67% cut in reporting time since integrating the AI with its Epic electronic health record.